CN106866618B - The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines - Google Patents

The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines Download PDF

Info

Publication number
CN106866618B
CN106866618B CN201710195054.1A CN201710195054A CN106866618B CN 106866618 B CN106866618 B CN 106866618B CN 201710195054 A CN201710195054 A CN 201710195054A CN 106866618 B CN106866618 B CN 106866618B
Authority
CN
China
Prior art keywords
crystal
thiophene
schiff base
follows
butane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201710195054.1A
Other languages
Chinese (zh)
Other versions
CN106866618A (en
Inventor
谭学杰
李坤
邢殿香
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qilu University of Technology
Original Assignee
Qilu University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qilu University of Technology filed Critical Qilu University of Technology
Priority to CN201710195054.1A priority Critical patent/CN106866618B/en
Publication of CN106866618A publication Critical patent/CN106866618A/en
Application granted granted Critical
Publication of CN106866618B publication Critical patent/CN106866618B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of butyl connection thiophene Schiff base dimer crystal, appearance be in colorless and transparent bulk, 68.9-69.6 DEG C of fusing point, molecular formula C14H16N2S2, molecular weight 276.42, chemical name are as follows: (N1E,N4E)‑N1,N4- two (thiophene -2- methylene) butane-Isosorbide-5-Nitrae-diamines, structure are as follows:The crystal category rhombic system, P212121Space group,α=β=γ=90 °,

Description

The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines
Technical field:
The present invention relates to organic synthesis, optical material and field of medicinal chemistry, use one step of better simply raw material and method Synthesize target product.
Background technique:
Symmetry plays important role in vital movement, therefore dimer is that one kind is generally deposited in natural products Structure type.In technical field of material chemistry, dimeric structure be often used in photoelectric material, supramolecular materials, functional dye, In the building of the new materials such as fluorescent material;Fluorescent material based on organic dimeric structure is widely used in optics electricity Sub- device, DNA diagnosis, Optochemical sensor, organic pigment, dyestuff, fluorescent whitening agent, photooxidant, fluorescent paint, laser dye Material, organic electroluminescence device (ELD) chemistry and biochemical analysis, solar energy trap, anti-fake mark, pharmaceutical indications and laser etc. Field;In field of medicinal chemistry, dimer often shows better activity than corresponding monomer;With the novel of excellent properties The design and synthesis of dimer material are always material scholar and the direction that Pharmaceutical Chemist is made great efforts.
Schiff base is a kind of compound that structure is more special, can be synthesized according to the difference for introducing group different types of Schiff base;Schiff base has important application in medicine, catalysis, analytical chemistry, corrosion and the fields such as photochromic, for example, Medical domain, Schiff base have antibacterial, sterilization, antitumor, antiviral bioactivity;In optical material field, due to its richness The characteristics of electronics and rigid plane, makes it have good fluorescence property and nonlinear optical property;In view of Schiff base dimerization Connection chain of body itself can have variation abundant, before optical material and field of medicinal chemistry also have good application Scape.
Summary of the invention
1, structural characterization
The contents of the present invention are one kind to be prepared by a variety of methods with butyl (i.e.-(CH2)4) be connection chain west Not alkali conjugated dimmer crystal, the structure of the dimer crystal and related characterization parameter are as follows:
The compound appearance be in colorless and transparent bulk crystals, 68.9-69.6 DEG C of fusing point, molecular formula C14H16N2S2, molecular weight It is 276.42, chemical name are as follows: (N1E,N4E)-N1,N4- two (thiophene -2- methylene) butane-Isosorbide-5-Nitrae-diamines, english system name Are as follows: (N1E,N4E)-N1,N4- bis (thiophen-2-ylmethylene) butane-1,4-diamine, structure are as follows:
Elemental analysis shows that the percentage composition of the dimer C, H, N are respectively 60.98%, 5.96% and 10.27% (to press Molecular formula C14H16N2S2The theoretical value of calculating is respectively 60.83%, 5.83% and 10.13%);Single crystal structure analysis shows it Crystallization is rhombic system, P212121Space group,α=β= γ=90 °,Z=4, attached drawing 1, attached drawing 2 are the hot ellipsoid crystal structure figure and crystalline substance of the compound respectively Body structure accumulation graph, it is related1HNMR spectrum,13CNMR spectrum is shown in attached drawing 3 and attached drawing 4 respectively.
2, synthetic method
It is characterized in that in the compound synthesis method: using 2 thiophene carboxaldehyde and butanediamine as raw material, being synthesized using solution Or solid-phase synthesis.Steps are as follows:
1) 2 thiophene carboxaldehyde and butanediamine are dissolved in respectively in suitable organic solvent, it is then mixed by certain molar ratio It closes, is stirred to react certain time at a certain temperature;It can also not have to organic solvent, directly mix two kinds of reactants, grinding Reaction.
2) when liquid phase reactor, obtained solution is removed into most of solvent using certain method, powder or knot can be obtained Crystalline object, as target product;When solid phase reaction, grinding certain time can obtain target product.
3) target product can recrystallize in suitable organic solvent with purified product.
Preferably, above-mentioned reaction dissolvent or recrystallization are selected from solvent: methanol, ethyl acetate, methylene chloride, ethyl alcohol, second Nitrile, acetone, chloroform, tetrahydrofuran, toluene, N,N-dimethylformamide.
Preferably, the reaction molar ratio of 2 thiophene carboxaldehyde and butanediamine is 1:2 to 4:1.
Preferably, the reaction temperature is room temperature to being heated to reflux.
Preferably, the reaction time are as follows: 0.5-12 hours.
Preferably, the method for removing solvent is nature volatilization or often/vacuum distillation.
The beneficial effects of the present invention are: function that can be more complicated with fairly simple step and reactant one-step synthesis Molecular material, and separation method is simple.
3, ultraviolet and photoluminescent property.
10-5The ultraviolet spectra that this compound is tested in mol/L ethanol solution finds that it has purple at 261nm and 279nm Outer absorption peak, as shown in Fig. 5;It is square in b3lyp/6-311+g (d, p) with TD-DFT theory by Gaussian03 software The ultraviolet spectra of the compound is calculated under method/base group, calculated result is listed in attached drawing 6;It can be found that calculating gained spectrogram and reality It tests result and coincide fine, such as calculate two main strong absworption peaks of gained and be located at 249nm and 279nm, one of absorption Peak and experimental result differ only by 12nm, another absorption peak is then identical;Found by orbit analysis, the two absorption peaks be by What π → π * transition generated.
10-5In mol/L ethanol solution, it is respectively the ultraviolet excitation of 361nm and 379nm with wavelength, tests this chemical combination The photoluminescent property of object finds that it has strong fluorescent emission between 400~500nm, and fluorescence spectrum is shown in attached drawing 7;It is shone with ultraviolet lamp It penetrates, naked eyes visible blue fluorescence.
Synthesis, such as following documents it is worth noting that, the dimer compound is reported in more documents: L.N.Khokhlova,S.Germane,N.P.Erchak,_E.Lukevits,Chem.Heterocycl.Com.30(1994) 279-282 (report fusing point be 75 DEG C), but so far there are no that someone obtains the high purity single crystal of the compound, therefore reported in the literature The crystal that fusing point is obtained with us is different from;We compared non-crystallization purifying head product and the crystal after recrystallization it is glimmering Light property finds that the fluorescence intensity difference of the two is very big, tests the solid fluorescence of same quality, the fluorescence intensity of crystal is probably Twice or more of head product;With ultraviolet light irradiation, head product can not observe with the naked eye apparent fluorescence, use even if increasing solid Amount, fluorescence intensity are also nothing like crystal state.
4, anti tumor activity in vitro.
A549 lung carcinoma cell in logarithmic phase growth is become into unicellular, use with 0.25% trypsin digestion cell It is 1.25 × 10 that concentration, which is made, in F12K culture solution containing 10% fetal calf serum7The single cell suspension of a/L, by cell inoculation in 96 In well culture plate, (the every hole 2.5 × 10 every 200 μ L of hole3A cell).96 porocyte culture plates are placed in CO2In incubator, 37 DEG C, 5%CO2Under the conditions of, cultivate 48h.
When inner cell covers with (90% is full) when hole, this Schiff base solution (200 of various dose is added by experimental group The hole μ L/), making the final concentration of untested compound is respectively 5 μM, 10 μM, 50 μM, 100 μM, 200 μM, and every group sets 3 multiple holes, culture 96h。
It is separately added into the MTT that 20 μ L concentration are 0.5g/L in each hole, continues to cultivate 4h, MTT is made to be reduced to first a ceremonial jade-ladle, used in libation (Formazan).After whole supernatants are sucked out, the DMSO of 200 μ L is added in every hole, is shaked 15min, is made first a ceremonial jade-ladle, used in libation after completely dissolution, is transported With the absorbance (OD value) at enzyme-linked immunosorbent assay instrument measurement 490nm.Then it is calculated according to the following formula:
Cell inhibitory rate %=(control group OD value-experimental group OD value)/control group OD value × 100%
Test result shows that the Schiff base is 182.0 μ to the IC50 (half-inhibitory concentration of drug) of lung cell A549 M, this shows that the compound has mild inhibitory effect to lung carcinoma cell.
5, specific embodiment
Content in order to better understand the present invention further illustrates technology of the invention below by a specific embodiment Scheme:
Embodiment 1.
It weighs 2 thiophene carboxaldehyde 1.12g (0.01mol) to be dissolved in 30mL dehydrated alcohol, heating stirring adds to whole dissolutions Enter butanediamine 0.44g (0.005mol), is heated to reflux under stirring 6 hours, is filtered after being cooled to room temperature, filtrate is placed in a beaker standing Volatilization can obtain a large amount of lenticular precipitatings, will obtain head product after gained precipitating filtering, this head product can use recrystallizing methanol, obtain nothing Color bulk crystals, as target product.
Embodiment 2.
It weighs 2 thiophene carboxaldehyde 1.12g (0.01mol), is added butanediamine 0.44g (0.005mol), grinding 8 is small under room temperature When, paste is obtained, 20ml dehydrated alcohol is then added, is dissolved by heating, obtains colourless bulk crystals, as target product after cooling, Recrystallization can make purifying products.
6, Detailed description of the invention
Attached drawing 1 is the crystal structure figure of target compound, ellipsoid probability 30%.
Attached drawing 2 is the crystal structure accumulation graph of target compound, is observed along b axis direction.
Attached drawing 3 is target compound1H NMR spectra.
Attached drawing 4 is target compound13CNMR spectrogram.
Attached drawing 5 is the ultraviolet spectrogram (experimental result) of target compound.
Attached drawing 6 is the ultraviolet spectrogram (03 calculated result of Gaussian) of target compound.
Attached drawing 7 is the fluorescence spectra (experimental result) of target compound.

Claims (1)

1. the thiophene Schiff base dimer crystal of a kind of butyl connection or it is swollen in preparation treatment in pharmaceutically acceptable salt Application in tumor medicine, it is characterised in that: the tumour is lung cancer;The crystal appearance is in colorless and transparent bulk, fusing point 68.9- 69.6 DEG C, molecular formula C14H16N2S2, molecular weight 276.42, chemical name are as follows: (N1E,N4E)-N1,N4- two (thiophene -2- methylenes Base) butane-Isosorbide-5-Nitrae-diamines, structure is as follows:
The crystal category rhombic system, P212121Space group,α=β=γ=90 °, Z=4.
CN201710195054.1A 2017-03-29 2017-03-29 The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines Expired - Fee Related CN106866618B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710195054.1A CN106866618B (en) 2017-03-29 2017-03-29 The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710195054.1A CN106866618B (en) 2017-03-29 2017-03-29 The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines

Publications (2)

Publication Number Publication Date
CN106866618A CN106866618A (en) 2017-06-20
CN106866618B true CN106866618B (en) 2019-04-26

Family

ID=59159528

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710195054.1A Expired - Fee Related CN106866618B (en) 2017-03-29 2017-03-29 The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines

Country Status (1)

Country Link
CN (1) CN106866618B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109824647B (en) * 2019-04-08 2021-04-06 齐鲁工业大学 Preparation and application of 4-hydroxybenzophenone hydrazone-2-acetylthiophene Schiff base
CN110590763B (en) * 2019-09-30 2022-09-30 齐鲁工业大学 Structure, preparation and application of 2-thiazole formaldehyde-thiophene Schiff base

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103073510B (en) * 2013-03-01 2014-12-17 齐鲁工业大学 Structure, preparation and application of new pyrazinyl schiff base compound

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Synthesis and evaluation of certain symmetrical Schiff bases as inhibitors of MDA-MB-241 human breast cancer cell proliferaton;Smaail Radi等;《Letters in Drug Design & Discovery》;20160229;第13卷;第205-209页
Two families of bis(imido) symmetrical Schiff bases: X-ray crystal structure and optical properties;Xiao-Na Ma等;《Journal of Molecular Structure》;20170224;第1137卷;第681-691页

Also Published As

Publication number Publication date
CN106866618A (en) 2017-06-20

Similar Documents

Publication Publication Date Title
CN107266348B (en) Preparation, structure and the purposes of 4-acetylbiphenyl hydrazone -3- indolecarboxaldehyde Schiff base
CN104945302A (en) Structure, preparation and application of benzil dihydrazone-indole-3-carboxaldehyde dual-Schiff base
CN101580477A (en) Dehydroabietylamine derivatives and application thereof in bactericidal and antineoplastic medicaments
CN106866618B (en) The preparation and use of two (thiophene -2- methylene) butane -1,4- diamines
CN109679109A (en) A kind of orange organic supermolecular polymer and the preparation method and application thereof
CN106749167B (en) The preparation and use of two (thiophene -2- methylene) propane -1,3- diamines
CN107043345B (en) 4-acetylbiphenyl hydrazone-indoline -2,3- diketone Schiff base preparation, structure and purposes
CN107266349B (en) Preparation, structure and the purposes of 4-acetylbiphenyl hydrazone -2- indolecarboxaldehyde Schiff base
CN106866619B (en) The preparation and use of two (thiophene -2- methylene) dodecane -1,12- diamines
CN110606843B (en) Structure, preparation and application of bipyridyl ketone hydrazone-2-acetylpyrazine
CN106008591B (en) A kind of synthesis of complex, sign and active anticancer assay method
Ooyama et al. Photophysical properties and photostability of novel symmetric polycyclicphenazine-type fluorescent dyes and the dye-doped films
CN110790695A (en) Synthesis and application of benzil hydrazone-N-methyl-3-indole formaldehyde
CN107118147B (en) Preparation, structure and the purposes of 4-acetylbiphenyl hydrazone -3- acetylindole Schiff base
CN107033063B (en) Preparation, structure and the purposes of 4-acetylbiphenyl hydrazone -4- indolecarboxaldehyde Schiff base
CN106831485A (en) Two(4 methoxybenzylidenes)The preparation and use of the diamines of butane 1,4
CN110698383B (en) Structure, synthesis and application of benzil hydrazone-3-acetyl indole
CN106928090A (en) Two(4 methoxybenzylidenes)The preparation and use of the diamines of propane 1,3
CN105348146B (en) Structure, preparation and use of benzil hydrazone-chlorobenzaldehyde bis-Schiff base
CN106946735A (en) Two(4 methoxybenzylidenes)The preparation and use of the diamines of dodecane 1,12
CN107043344B (en) Preparation, structure and the purposes of 4-acetylbiphenyl hydrazone-N- methyl -3- indolecarboxaldehyde Schiff base
Wang et al. Crystal engineering construction of caffeic acid derivatives with potential applications in pharmaceuticals and degradable polymeric materials
CN109824572A (en) Structure, the preparation and use of -3 indolecarboxaldehyde schiff bases of 4- dihydroxy benaophenonel hydrazone -1- methyl
CN109912491A (en) 4- dihydroxy benaophenonel hydrazone-isatin schiff bases preparation and use
CN105367445B (en) Preparation, structure and application of benzyl dihydrazone-N-mono-(2-hydroxy-4-diethylin-1-formyl benzene)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190426

Termination date: 20200329